Cargando…

Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient

We report for the first time a case of disseminated infection caused by Peziza ostracoderma, a mold not previously associated with invasive infections in humans. P. ostracoderma occurs in natural and sterilized soil and may cause hypersensitivity pneumonitis in greenhouse workers. The immunocompromi...

Descripción completa

Detalles Bibliográficos
Autores principales: Kinch, Amelie, Furebring, Mia, Chryssanthou, Erja, Hallböök, Helene
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867948/
https://www.ncbi.nlm.nih.gov/pubmed/36698700
http://dx.doi.org/10.1016/j.mmcr.2022.12.005
_version_ 1784876444456845312
author Kinch, Amelie
Furebring, Mia
Chryssanthou, Erja
Hallböök, Helene
author_facet Kinch, Amelie
Furebring, Mia
Chryssanthou, Erja
Hallböök, Helene
author_sort Kinch, Amelie
collection PubMed
description We report for the first time a case of disseminated infection caused by Peziza ostracoderma, a mold not previously associated with invasive infections in humans. P. ostracoderma occurs in natural and sterilized soil and may cause hypersensitivity pneumonitis in greenhouse workers. The immunocompromised patient presented with neutropenic fever that did not respond to broad-spectrum antibiotics and developed multiple skin and lung lesions. A skin biopsy demonstrated an angioinvasive mold, identified as Peziza ostracoderma by culture and DNA sequencing. Minimum inhibitory concentration (MIC) for amphotericin B was 0.125 mg/L, for isavuconazole 0.125 mg/L, for voriconazole 0.06 mg/L, and for posaconazole 0.03 mg/L. The skin lesions have resolved completely, and the lung lesions have decreased significantly in size after 14 months of mold-active antifungal therapy, mostly isavuconazole. In conclusion, Peziza species can be opportunistic pathogens causing considerable morbidity in immunocompromised hosts. The infection may be successfully treated with mold-active antifungal drugs.
format Online
Article
Text
id pubmed-9867948
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-98679482023-01-24 Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient Kinch, Amelie Furebring, Mia Chryssanthou, Erja Hallböök, Helene Med Mycol Case Rep Case Report We report for the first time a case of disseminated infection caused by Peziza ostracoderma, a mold not previously associated with invasive infections in humans. P. ostracoderma occurs in natural and sterilized soil and may cause hypersensitivity pneumonitis in greenhouse workers. The immunocompromised patient presented with neutropenic fever that did not respond to broad-spectrum antibiotics and developed multiple skin and lung lesions. A skin biopsy demonstrated an angioinvasive mold, identified as Peziza ostracoderma by culture and DNA sequencing. Minimum inhibitory concentration (MIC) for amphotericin B was 0.125 mg/L, for isavuconazole 0.125 mg/L, for voriconazole 0.06 mg/L, and for posaconazole 0.03 mg/L. The skin lesions have resolved completely, and the lung lesions have decreased significantly in size after 14 months of mold-active antifungal therapy, mostly isavuconazole. In conclusion, Peziza species can be opportunistic pathogens causing considerable morbidity in immunocompromised hosts. The infection may be successfully treated with mold-active antifungal drugs. Elsevier 2022-12-24 /pmc/articles/PMC9867948/ /pubmed/36698700 http://dx.doi.org/10.1016/j.mmcr.2022.12.005 Text en © 2023 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Case Report
Kinch, Amelie
Furebring, Mia
Chryssanthou, Erja
Hallböök, Helene
Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient
title Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient
title_full Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient
title_fullStr Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient
title_full_unstemmed Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient
title_short Invasive fungal infection by Peziza ostracoderma in an immunocompromised patient
title_sort invasive fungal infection by peziza ostracoderma in an immunocompromised patient
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9867948/
https://www.ncbi.nlm.nih.gov/pubmed/36698700
http://dx.doi.org/10.1016/j.mmcr.2022.12.005
work_keys_str_mv AT kinchamelie invasivefungalinfectionbypezizaostracodermainanimmunocompromisedpatient
AT furebringmia invasivefungalinfectionbypezizaostracodermainanimmunocompromisedpatient
AT chryssanthouerja invasivefungalinfectionbypezizaostracodermainanimmunocompromisedpatient
AT hallbookhelene invasivefungalinfectionbypezizaostracodermainanimmunocompromisedpatient